The Food and Drug Administration's process for approving new drugs : report /

Polydrug abuse-the response of the medical profession and the pharmaceutical industry : a report of the Select Committee on Narcotics Abuse and Control, Ninety-fifth Congress, second session.

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

January 1979

"SCNAC-95-2-16."At head of title: Committee print. 95th Congress, 2d session. House of Representativ...

Second interim report on nuclear weapons in Europe /

United States. Congress. Senate. Committee on Foreign Relations.
North Atlantic Assembly. Special Committee on Nuclear Weapons in Europe.

January 1983

January 1983."Star print."At head of title: Committee print.Includes bibliographical references.Mode...

Science support by the Department of Defense : report /

January 1987

"Serial II"."December 1986".At head of title: Committee print.Includes bibliographical references.Mo...

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee.

January 1982

Item 1016-A, 1016-B (microfiche).Includes bibliographical references.Mode of access: Internet

The Food and Drug Administration's process for approving new drugs [microform] : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.

United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.

Reuse of record except for individual research requires license from Congressional Information Servi...

The Information Science and Technology Act of 1981 : report /

Bortnick, Jane
United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.
Library of Congress. Congressional Research Service.

January 1982

"Serial DD.""June 1982."At head of title: Committee print.Mode of access: Internet

[D]HHS publication no. (FDA).

United States. Dept. of Health and Human Services.
United States. Food and Drug Administration.

Series consists of publications by the Food and Drug Administration.Mode of access: Internet

Food and Drug Administration-- what it is, and does.

United States. Food and Drug Administration.

"May 1958"--P. 4.Reproduced from typewritten copy.Caption title.Mode of access: Internet

The Regulatory environment for science : report /

United States. Congress. House. Committee on Science and Technology. Task Force on Science Policy.
United States. Congress. Office of Technology Assessment.

January 1986

"December 1986.""Serial Y."At head of title: Committee print.Bibliography: p. 163-168.Mode of access...

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

United States. General Accounting Office.

"B-235944"--P. [1]"GAO/PEMD-90-15.""April 1990."Cover title.Includes bibliographical references (p. ...

FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies /

United States. General Accounting Office.

January 1988

At head of title : Report to the ranking minority member, Special Committee on Aging, U.S. Senate."B...

Final report /

United States. American Indian Policy Review Commission.

January 1977

At head of title: Committee print.Includes bibliographical references.Mode of access: Internet

Prescription drugs : information on selected drug utilization review systems : report to the Chairman, Special Committee on Aging, U.S. Senate/

United States. General Accounting Office.

January 1989

Running title: Prescription drug utilization review systems."GAO/PEMD-89-18""May 1989."Cover title.M...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

Polydrug abuse-the response of the medical profession and the pharmaceutical industry : a report of the Select Committee on Narcotics Abuse and Control, Ninety-fifth Congress, second session.

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

January 1979

"SCNAC-95-2-16."At head of title: Committee print. 95th Congress, 2d session. House of Representativ...

Second interim report on nuclear weapons in Europe /

United States. Congress. Senate. Committee on Foreign Relations.
North Atlantic Assembly. Special Committee on Nuclear Weapons in Europe.

January 1983

January 1983."Star print."At head of title: Committee print.Includes bibliographical references.Mode...

Science support by the Department of Defense : report /

January 1987

"Serial II"."December 1986".At head of title: Committee print.Includes bibliographical references.Mo...

The regulation of new drugs by the Food and Drug Administration : the new drug review process : hearings before a subcommittee of the Committee on Government Operations, House of Representatives, Ninety-seventh Congress, second session, August 3 and 4, 1982.

United States. Congress. House. Committee on Government Operations. Intergovernmental Relations and Human Resources Subcommittee.

January 1982

Item 1016-A, 1016-B (microfiche).Includes bibliographical references.Mode of access: Internet

The Food and Drug Administration's process for approving new drugs [microform] : oversight : hearings before the Subcommittee on Science, Research, and Technology of the Committee on Science and Technology, U.S. House of Representatives, Ninety-sixth Congress, first session, June 19, 21, July 11, 1979.

United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.

Reuse of record except for individual research requires license from Congressional Information Servi...

The Information Science and Technology Act of 1981 : report /

Bortnick, Jane
United States. Congress. House. Committee on Science and Technology. Subcommittee on Science, Research, and Technology.
Library of Congress. Congressional Research Service.

January 1982

"Serial DD.""June 1982."At head of title: Committee print.Mode of access: Internet

[D]HHS publication no. (FDA).

United States. Dept. of Health and Human Services.
United States. Food and Drug Administration.

Series consists of publications by the Food and Drug Administration.Mode of access: Internet

Food and Drug Administration-- what it is, and does.

United States. Food and Drug Administration.

"May 1958"--P. 4.Reproduced from typewritten copy.Caption title.Mode of access: Internet

The Regulatory environment for science : report /

United States. Congress. House. Committee on Science and Technology. Task Force on Science Policy.
United States. Congress. Office of Technology Assessment.

January 1986

"December 1986.""Serial Y."At head of title: Committee print.Bibliography: p. 163-168.Mode of access...

FDA drug review : postapproval risks, 1976-85 : report to the Chairman, Subcommittee on Human Resources and Intergovernmental Relations, Committee on Government Operations, House of Representatives.

United States. General Accounting Office.

"B-235944"--P. [1]"GAO/PEMD-90-15.""April 1990."Cover title.Includes bibliographical references (p. ...

FDA's reviews of new drugs : changes needed in process for reviewing and reporting on clinical studies /

United States. General Accounting Office.

January 1988

At head of title : Report to the ranking minority member, Special Committee on Aging, U.S. Senate."B...

Final report /

United States. American Indian Policy Review Commission.

January 1977

At head of title: Committee print.Includes bibliographical references.Mode of access: Internet

Prescription drugs : information on selected drug utilization review systems : report to the Chairman, Special Committee on Aging, U.S. Senate/

United States. General Accounting Office.

January 1989

Running title: Prescription drug utilization review systems."GAO/PEMD-89-18""May 1989."Cover title.M...

Food safety and quality : FDA needs stronger controls over the approval process for new animal drugs : report to the Chairman, Human Resources and Intergovernmental Relations Subcommittee, Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House of Representatives. Committee on Government Operations. Human Resources and Intergovernmental Relaltions Subcommittee.

"B-246269"--P. 1."GAO/RCED-92-63.""January 1992."Cover title.Includes bibliographical references.Mod...

Drug control : reauthorization of the Office of National Drug Control Policy : report to the Committee on Government Operations, House of Representatives /

United States. General Accounting Office.
United States. Congress. House. Committee on Government Operations.

"B-254530"--P. [1]."GAO/GGD-93-144.""September 1993."Cover title.Includes bibliographical references...

Polydrug abuse-the response of the medical profession and the pharmaceutical industry : a report of the Select Committee on Narcotics Abuse and Control, Ninety-fifth Congress, second session.

United States. Congress. House. Select Committee on Narcotics Abuse and Control.

January 1979

"SCNAC-95-2-16."At head of title: Committee print. 95th Congress, 2d session. House of Representativ...

Second interim report on nuclear weapons in Europe /

United States. Congress. Senate. Committee on Foreign Relations.
North Atlantic Assembly. Special Committee on Nuclear Weapons in Europe.

January 1983

January 1983."Star print."At head of title: Committee print.Includes bibliographical references.Mode...

Science support by the Department of Defense : report /

January 1987

"Serial II"."December 1986".At head of title: Committee print.Includes bibliographical references.Mo...

The Food and Drug Administration's process for approving new drugs : report /

Abstract

Extracted data

The Food and Drug Administration's process for approving new drugs : report /

Abstract

Extracted data

Related items

Related items